AlbaƱo, Crispina I.

HRN: 08-71-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/25/2025
11/30/2025
IV
2.25gms
Q6
Renal Dosing (Sepsis)
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: